Novel humanized murine models for HIV research

Current HIV/AIDS Reports

Volumn 6, Issue 1, 2009, Pages 13-19

  Denton, Paul W ^b   Garcia, J Victor ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 2 RECEPTOR GAMMA; MICROBICIDE; RAG2 PROTEIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOID TISSUE; MEDICAL RESEARCH; MODEL; NONHUMAN; NONOBESE DIABETIC MOUSE; PATHOGENESIS; PROPHYLAXIS; REVIEW; SCID MOUSE; VAGINA MUCOSA; VIRUS TRANSMISSION; ANIMAL; DISEASE MODEL; DRUG EFFECT; FEMALE; FETAL TISSUE TRANSPLANTATION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; LIVER TRANSPLANTATION; MOUSE; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; RESEARCH; THYMUS; TRANSPLANTATION; VIROLOGY;

AIDS VACCINES; ANIMALS; ANTI-HIV AGENTS; DISEASE MODELS, ANIMAL; FEMALE; FETAL TISSUE TRANSPLANTATION; HIV INFECTIONS; HIV-1; HUMANS; LIVER TRANSPLANTATION; MICE; MICE, INBRED NOD; MICE, SCID; RESEARCH; THYMUS GLAND;

EID: 61449091512     PISSN: 15483568     EISSN: 15483576     Source Type: Journal    
DOI: 10.1007/s11904-009-0003-2     Document Type: Review

References (50)

1. Mosier DE, Gulizia RJ, Baird SM, Wilson DB: Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988, 335:256-259.
2. Baumann JG, Unutmaz D, Miller MD, et al.: Murine T cells potently restrict human immunodeficiency virus infection. J Virol 2004, 78:12537-12547.
3. McCune J, Kaneshima H, Krowka J, et al.: The SCID-hu mouse: a small animal model for HIV infection and pathogenesis. Annu Rev Immunol 1991, 9:399-429.
4. McCune JM, Kaneshima H, Lieberman M, et al.: The SCID-hu mouse: current status and potential applications. Curr Top Microbiol Immunol 1989, 152:183-193.
5. Brenchley JM, Price DA, Douek DC: HIV disease: fallout from a mucosal catastrophe? Nat Immunol 2006, 7:235-239.
6. Dandekar S: Pathogenesis of HIV in the gastrointestinal tract. Curr HIV/AIDS Rep 2007, 4:10-15.
7. Shultz LD, Ishikawa F, Greiner DL: Humanized mice in translational biomedical research. Nat Rev Immunol 2007, 7:118-130.
8. Garcia S, Dadaglio G, Gougeon ML: Limits of the human-PBL-SCID mice model: severe restriction of the V beta T-cell repertoire of engrafted human T cells. Blood 1997, 89:329-336.
9. Saxon A, Macy E, Denis K, et al.: Limited B cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans. J Clin Invest 1991, 87:658-665.
10. McCune JM, Namikawa R, Kaneshima H, et al.: The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988, 241:1632-1639.
11. D'Cruz OJ, Uckun FM: Limitations of the human-PBL-SCID mouse model for vaginal transmission of HIV-1. Am J Reprod Immunol 2007, 57:353-360.
12. Di Fabio S, Van Roey J, Giannini G, et al.: Inhibition of vaginal transmission of HIV-1 in hu-SCID mice by the non-nucleoside reverse transcriptase inhibitor TMC120 in a gel formulation. AIDS 2003, 17:1597-1604.
13. Khanna KV, Whaley KJ, Zeitlin L, et al.: Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent. J Clin Invest 2002, 109:205-211.
14. Lederman MM, Offord RE, Hartley O: Microbicides and other topical strategies to prevent vaginal transmission of HIV. Nat Rev Immunol 2006, 6:371-382.
15. Su L, Kaneshima H, Bonyhadi M, et al.: HIV-1-induced thymocyte depletion is associated with indirect cytopathogenicity and infection of progenitor cells in vivo. Immunity 1995, 2:25-36.
16. Stoddart CA, Bales CA, Bare JC, et al.: Validation of the SCID-hu thy/liv mouse model with four classes of licensed antiretrovirals. PLoS ONE 2007, 2: e655.
17. Traggiai E, Chicha L, Mazzucchelli L, et al.: Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004, 304:104-107.
18. Manz MG: Human-hemato-lymphoid-system mice: opportunities and challenges. Immunity 2007, 26:537-541.
19. Berges BK, Wheat WH, Palmer BE, et al.: HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model. Retrovirology 2006, 3:76.
20. Ter Brake O, Legrand N, von Eije KJ, et al.: Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)(c)(-/-)) mouse model. Gene Ther 2008 Jul 31 (Epub ahead of print).
21. Van Duyne R, Cardenas J, Easley R, et al.: Effect of transcription peptide inhibitors on HIV-1 replication. Virology 2008, 376:308-322.
22. An DS, Poon B, Ho Tsong, et al.: Use of a novel chimeric mouse model with a functionally active human immune system to study human immunodeficiency virus type 1 infection. Clin Vaccine Immunol 2007, 14:391-396.
23. -/- mice.
24. -/- mice.
25. Gorantla S, Sneller H, Walters L, et al.: Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice. J Virol 2007, 81:2700-2712.
26. -/- mice.
27. Zhang L, Kovalev GI, Su L: HIV-1 infection and pathogenesis in a novel humanized mouse model. Blood 2007, 109:2978-2981.
28. Hiramatsu H, Nishikomori R, Heike T, et al.: Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/gammcnull mice model. Blood 2003, 102:873-880.
29. Ishikawa F, Yasukawa M, Lyons B, et al.: Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood 2005, 106:1565-1573.
30. Watanabe S, Ohta S, Yajima M, et al.: Humanized NOD/SCID/IL2R {gamma}null mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis. J Virol 2007, 81:13259-13264.
31. -/- mice.
32. Kumar P, Ban HS, Kim SS, et al.: T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 2008, 134:577-586.
33. •• Melkus MW, Estes JD, Padgett-Thomas A, et al.: Humanized mice mount specific adaptive and innate immune response to EBV and TSST-1. Nat Med 2006, 12:1316-1322. This article describes in detail the development of humanized BLT mice demonstrating the bona fide development of functional human T cells in the context of a human thymic microenvironment.
34. Wege AK, Melkus MW, Denton PW, et al.: Functional and phenotypic characterization of the humanized BLT mouse model. Curr Top Microbiol Immunol 2008, 324:149-165.
35. •• Tonomura N, Habiro K, Shimizu A, et al.: Antigen-specific human T-cell responses and T cell-dependent production of human antibodies in a humanized mouse model. Blood 2008, 111:4293-4296. This paper presents evidence of antigen-specific human B-cell responses and T-cell-dependent production of human antibodies in BLT mice.
36. Lan P, Tonomura N, Shimizu A, et al.: Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation. Blood 2006, 108:487-492.
37. Tonomura N, Shimizu A, Wang S, et al.: Pig islet xenograft rejection in a mouse model with an established human immune system. Xenotransplantation 2008, 15:129-135.
38. Makida R, Hofer MF, Takase K, et al.: Bacterial superantigens induce V beta-specific T cell receptor internalization. Mol Immunol 1996, 33:891-900.
39. •• Sun Z, Denton PW, Estes JD, et al.: Intrarectal transmission, systemic infection and CD4+ T cell depletion in humanized mice infected with HIV-1. J Exp Med 2007, 204:705-714. This paper presents the most extensive characterization of the specific human reconstitution of the GALT of BLT mice, the rectal transmission of HIV, and the extensive sequela caused by a highly pathogenic virus.
40. Brenchley JM, Schacker TW, Ruff LE, et al.: CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004, 200:749-759.
41. Bell SJ, Rigby R, English N, et al.: Migration and maturation of human colonic dendritic cells. J Immunol 2001, 166:4958-4967.
42. Abuzakouk M, Carton J, Feighery C, et al.: CD4+ CD8+ and CD8alpha+ beta- T lymphocytes in human small intestinal lamina propria. Eur J Gastroenterol Hepatol 1998, 10:325-329.
43. Carton J, Byrne B, Madrigal-Estebas L, et al.: CD4+CD8+ human small intestinal T cells are decreased in coeliac patients, with CD8 expression downregulated on intraepithelial T cells in the active disease. Eur J Gastroenterol Hepatol 2004, 16:961-968.
44. Lynch S, Kelleher D, Feighery C, et al.: Flow cytometric analysis of intraepithelial lymphocytes from human small intestinal biopsies reveals populations of CD4+CD8+ and CD8[alpha][alpha]+ cells. Eur J Gastroenterol Hepatol 1993, 5:907-912.
45. •• Denton PW, Estes JD, Sun Z, et al.: Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLoS Med 2008, 5: e16. This article characterized the human reconstitution of the female reproductive tract of BLT mice that facilitates vaginal HIV-1 transmission in BLT mice and demonstrated the protective effect of pre-exposure prophylaxis with antiretroviral drugs.
46. Foster JL, Garcia JV: Role of Nef in HIV-1 replication and pathogenesis. Adv Pharmacol 2007, 55:389-409.
47. De Boer RJ: Understanding the failure of CD8+ T-cell vaccination against simian/human immunodeficiency virus. J Virol 2007, 81:2838-2848.
48. Koff WC, Johnson PR, Watkins DI, et al.: HIV vaccine design: insights from live attenuated SIV vaccines. Nat Immunol 2006, 7:19-23.
49. McMichael AJ, Hanke T: HIV vaccines 1983-2003. Nat Med 2003, 9:874-880.
50. Hofer U, Baenziger S, Heikenwalder M, et al.: RAG2-/-gamma(c)-/- mice transplanted with CD34+ cells from human cord blood show low levels of intestinal engraftment and are resistant to rectal transmission of human immunodeficiency virus. J Virol 2008, 82:12145-12153.